Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy in gastrointestinal malignancies.

D G Haller1

  • 1University of Pennsylvania School of Medicine, Philadelphia.

Seminars in Oncology
|June 1, 1988
PubMed
Summary

Gastrointestinal (GI) cancers require new treatments. Combining chemotherapy and radiotherapy shows promise for better local control and survival, with mitomycin C being a key agent.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysis.

ESMO open·2025
Same author

Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population†.

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer--an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009.

Annals of oncology : official journal of the European Society for Medical Oncology·2010
Same author

Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer.

Journal of surgical oncology·2007
Same author

A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancer.

British journal of cancer·2005

Area of Science:

  • Oncology
  • Gastroenterology

Background:

  • Gastrointestinal (GI) cancers are frequent and diverse, often resisting sole chemotherapy treatments.
  • Current therapies like chemotherapy and radiotherapy have limitations in improving survival and controlling systemic disease.

Purpose of the Study:

  • To review the current status of chemotherapy for GI malignancies.
  • To emphasize the role of mitomycin C in combination therapies for GI cancers.

Main Methods:

  • Review of existing literature on chemotherapy and combined modality treatments for GI cancers.
  • Analysis of treatment outcomes, including local control, systemic disease, and patient tolerance.

Main Results:

  • Single-modality chemotherapy is often insufficient for GI cancers.
  • Combined radiotherapy and chemotherapy, exemplified by anal cancer treatment, offer improved outcomes.
  • Mitomycin C is highlighted as a significant agent in GI cancer therapy.

Conclusions:

  • Combined modality treatments (surgery, radiotherapy, chemotherapy) are crucial for advancing GI cancer care.
  • Further exploration of combination therapies is warranted for diverse GI malignancies.
  • Individualized therapeutic strategies are essential for effective GI cancer management.

Related Experiment Videos